These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9873743)

  • 1. Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 modifications.
    Plummer JS; Berryman KA; Cai C; Cody WL; DiMaio J; Doherty AM; Edmunds JJ; He JX; Holland DR; Levesque S; Kent DR; Narasimhan LS; Rubin JR; Rapundalo ST; Siddiqui MA; Susser AJ; St-Denis Y; Winocour PD
    Bioorg Med Chem Lett; 1998 Dec; 8(23):3409-14. PubMed ID: 9873743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent bicyclic lactam inhibitors of thrombin: Part I: P3 modifications.
    St-Denis Y; Augelli-Szafran CE; Bachand B; Berryman KA; DiMaio J; Doherty AM; Edmunds JJ; Leblond L; Lévesque S; Narasimhan LS; Penvose-Yi JR; Rubin JR; Tarazi M; Winocour PD; Siddiqui MA
    Bioorg Med Chem Lett; 1998 Nov; 8(22):3193-8. PubMed ID: 9873701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent and selective bicyclic lactam inhibitors of thrombin. Part 4: transition state inhibitors.
    Bachand B; Tarazi M; St-Denis Y; Edmunds JJ; Winocour PD; Leblond L; Siddiqui MA
    Bioorg Med Chem Lett; 2001 Feb; 11(3):287-90. PubMed ID: 11212093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent and selective bicyclic lactam inhibitors of thrombin: Part 3: P1' modifications.
    Plummer JS; Berryman KA; Cai C; Cody WL; DiMaio J; Doherty AM; Eaton S; Edmunds JJ; Holland DR; Lafleur D; Levesque S; Narasimhan LS; Rubin JR; Rapundalo ST; Siddiqui MA; Susser A; St-Denis Y; Winocour P
    Bioorg Med Chem Lett; 1999 Mar; 9(6):835-40. PubMed ID: 10206546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel thrombin inhibitors incorporating weakly basic heterobicyclic P1-arginine mimetics: optimization via modification of P1 and P3 moieties.
    Kranjc A; Peterlin-Masic L; Ilas J; Prezelj A; Stegnar M; Kikelj D
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3251-6. PubMed ID: 15149685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin active site inhibitors: chemical synthesis, in vitro and in vivo pharmacological profile of a novel and selective agent BMS-189090 and analogues.
    Das J; Kimball SD; Reid JA; Wang TC; Lau WF; Roberts DG; Seiler SM; Schumacher WA; Ogletree ML
    Bioorg Med Chem Lett; 2002 Jan; 12(1):41-4. PubMed ID: 11738569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noncovalent tripeptidic thrombin inhibitors incorporating amidrazone, amine and amidine functions at P1.
    Lee K; Jung WH; Park CW; Park HD; Lee SH; Kwon OH
    Bioorg Med Chem Lett; 2002 Apr; 12(7):1017-22. PubMed ID: 11909707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo properties of bicyclic lactam inhibitors: a novel class of low molecular weight peptidomimetic thrombin inhibitors.
    Leblond L; Grouix B; Boudreau C; Yang Q; Siddiqui MA; Winocour PD
    Thromb Res; 2000 Nov; 100(3):195-209. PubMed ID: 11108907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncovalent thrombin inhibitors incorporating an imidazolylethynyl P1.
    Lee K; Jung WH; Kang M; Lee SH
    Bioorg Med Chem Lett; 2000 Dec; 10(24):2775-8. PubMed ID: 11133089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease inhibitors, part 13: Specific, weakly basic thrombin inhibitors incorporating sulfonyl dicyandiamide moieties in their structure.
    Clare BW; Scozzafava A; Supuran CT
    J Enzyme Inhib; 2001 Jan; 16(1):1-13. PubMed ID: 11496831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amidinohydrazones as guanidine bioisosteres: application to a new class of potent, selective and orally bioavailable, non-amide-based small-molecule thrombin inhibitors.
    Soll RM; Lu T; Tomczuk B; Illig CR; Fedde C; Eisennagel S; Bone R; Murphy L; Spurlino J; Salemme FR
    Bioorg Med Chem Lett; 2000 Jan; 10(1):1-4. PubMed ID: 10636229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological activity of novel rigid amidino-phenylalanine derivatives as inhibitors of thrombin.
    Mack H; Pfeiffer T; Hornberger W; Böhm HJ; Höffken HW
    J Enzyme Inhib; 1995; 9(1):73-86. PubMed ID: 8568568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, parallel synthesis, and crystal structures of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex.
    Parlow JJ; Case BL; Dice TA; Fenton RL; Hayes MJ; Jones DE; Neumann WL; Wood RS; Lachance RM; Girard TJ; Nicholson NS; Clare M; Stegeman RA; Stevens AM; Stallings WC; Kurumbail RG; South MS
    J Med Chem; 2003 Sep; 46(19):4050-62. PubMed ID: 12954058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based design of novel potent nonpeptide thrombin inhibitors.
    Hauel NH; Nar H; Priepke H; Ries U; Stassen JM; Wienen W
    J Med Chem; 2002 Apr; 45(9):1757-66. PubMed ID: 11960487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel bicyclic lactam inhibitors of thrombin: potency and selectivity optimization through P1 residues.
    Lévesque S; St-Denis Y; Bachand B; Préville P; Leblond L; Winocour PD; Edmunds JJ; Rubin JR; Siddiqui MA
    Bioorg Med Chem Lett; 2001 Dec; 11(24):3161-4. PubMed ID: 11720865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel benzo-fused lactam scaffolds as factor Xa inhibitors.
    Tamura SY; Goldman EA; Bergum PW; Semple JE
    Bioorg Med Chem Lett; 1999 Sep; 9(17):2573-8. PubMed ID: 10498211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzylamine-based selective and orally bioavailable inhibitors of thrombin.
    Lee K; Jung WH; Park CW; Hong CY; Kim IC; Kim S; Oh YS; Kwon OH; Lee SH; Park HD; Kim SW; Lee YH; Yoo YJ
    Bioorg Med Chem Lett; 1998 Sep; 8(18):2563-8. PubMed ID: 9873581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterocyclic thrombin inhibitors. Part 2: quinoxalinone derivatives as novel, potent antithrombotic agents.
    Ries UJ; Priepke HW; Hauel NH; Handschuh S; Mihm G; Stassen JM; Wienen W; Nar H
    Bioorg Med Chem Lett; 2003 Jul; 13(14):2297-302. PubMed ID: 12824021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of L-proline based aeruginosin 298-A analogs: optimization of the P1-moiety.
    Wang G; Goyal N; Hopkinson B
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3798-803. PubMed ID: 19447619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The design and synthesis of thrombin inhibitors: analogues of MD805 containing non-polar surrogates for arginine at the P1 position.
    Baettig U; Brown L; Brundish D; Dell C; Furzer A; Garman S; Janus D; Kane PD; Smith G; Walker CV; Cockcroft X; Ambler J; Mitchelson A; Talbot MD; Tweed M; Wills N
    Bioorg Med Chem Lett; 2000 Jul; 10(14):1563-6. PubMed ID: 10915051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.